Chinese Journal of Clinical Anatomy ›› 2024, Vol. 42 ›› Issue (1): 33-41.doi: 10.13418/j.issn.1001-165x.2024.1.07

Previous Articles     Next Articles

Ginsenoside Rg1 reduces the inflammatory response of microglia after oxygen glucose deprivation/resupply by inhibiting the NLRP3 inflammasome pathway

Wang Xinghang1, Ding Jiayuan2, Li Fang3, Bao Cuifen4*, Yan Lijing4*   

  1. 1. Department of Histology and Embryology,Jinzhou Medical University,Jinzhou 121001, Liaoning Province, China ;  2.Department of Human Anatomy,Jinzhou Medical University,Jinzhou 121001, Liaoning Province, China;  3. Department of Analytical Chemistry,Jinzhou Medical University,Jinzhou 121001, Liaoning Province, China;  4.Experimental Teaching Center of Basic Medicine, Jinzhou Medical University,Jinzhou 121001, Liaoning Province, China 
  • Received:2023-01-14 Online:2024-01-25 Published:2024-01-30

Abstract: Objective     To investigate the effect of ginsenoside Rg1 on the inflammatory response of microglia cells after oxygen-glucose deprivation/resupply injury through NLRP3 inflammasome pathway, and to further investigate its anti-inflammatory mechanism.   Methods    BV-2 microglia were randomly divided into six groups: No treatment group (Con), oxygen glucose deprivation/resupply group (OGD/R), ginsenoside Rg1 low, medium and high dose groups (0.1, 0.2, 0.4 mmol/L, Rg1L, Rg1M, Rg1H), MCC950 control group (0.05 mmol/L, MCC950). The cell proliferation was detected by CCK8. Immunofluorescence and western blotting were used to detect the expression of NLRP3 inflammasome-related protein in BV-2 microglia after treatment with different concentrations of ginsenoside Rg1 and MCC950 for 48 h. The expression levels of IL-1β and IL-18 in BV-2 microglia were detected by ELISA.    Results    Compared with Con group, Iba-1 green fluorescence was observed in the cytoplasm of BV-2 microglia cells treated with hypoxia and glucose deficiency/resupply. After OGD/R treatment of BV-2 microglia for 2h, the proliferation rate of BV-2 microglia cells showed an obvious downward trend after 48 h culture with different concentrations of ginsenoside Rg1 and MCC950. There were significant positive expressions of NLRP3, ASC, Caspase-1, IL-1β and IL-18 in the OGD/R group. The NLRP3 protein expression in Rg1L, Rg1M and Rg1H groups was significantly decreased, and the expression decreased with the increasing of drug concentration. The results showed that compared with OGD/R group, ginsenoside Rg1 and MCC950 inhibited the expression of NLRP3 in activated BV-2 microglia cells (P<0.01). Conclusions    Ginsenoside Rg1 may inhibit the expression levels of IL-1β and IL-18, thus inhibiting the inflammatory response by inhibiting the expressions of NLRP3, ASC, Caspase-1 and interfering with NLRP3 inflammasome synthesis.  

Key words: Ginsenoside Rg1; ,  , Oxygen and glucose deprivation/resupply; ,  , Microglia; ,  , Inflammation; ,  , NLRP3

CLC Number: